Literature DB >> 2664909

Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival.

M Tubiana1, A Courdi.   

Abstract

A large number of studies have investigated the relationship between the long-term survival and the percentage of tumor cells in S phase assessed by autoradiography after tritiated thymidine labelling, image cytometry, flow cytometry or labelling with an halogenated analog of thymidine, in various types of human solid tumors. The survey of the results clearly shows that the S-phase fraction (SPF) is of high prognostic significance in several types of cancers, in particular in breast cancers, non-Hodgkin lymphomas, ovarian cancers, neuroblastoma, bladder cancers and lung cancers. SPF was found of high independent significance in 10 of the 11 studies in which multivariate analyses of prognostic factors had been carried out. Proliferation appears generally to be of higher prognostic significance than ploidy. In view of the wide differences in the biological characteristics of the tumors studied, it is likely that the association between a high proliferation rate and the degree of tumor aggressiveness is a general feature of human solid tumors. However, high proliferative rate of tumor cells is probably not the cause of tumor biological aggressiveness but a variable associated with it. The extent to which cells escape from the regulatory systems which control their proliferation appears to be a good index of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664909     DOI: 10.1016/0167-8140(89)90113-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  41 in total

1.  Proliferating cell nuclear antigen expression in central nervous system neoplasms.

Authors:  A Allegranza; S Girlando; G L Arrigoni; S Veronese; F A Mauri; M Gambacorta; B Pollo; P Dalla Palma; M Barbareschi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation.

Authors:  Hiroyuki Nojima; Kazuhiro Seike; Chihiro Kosugi; Takashi Shida; Keiji Koda; Kenji Oda; Shigeyuki Kamata; Hiroshi Ishikura; Masaru Miyazaki
Journal:  World J Surg Oncol       Date:  2010-04-17       Impact factor: 2.754

3.  Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer.

Authors:  D A Rew
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

4.  The scientific bases of cancer management: at the interface between fundamental research and clinical practice.

Authors:  M Tubiana
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

6.  Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer.

Authors:  D W Visscher; S Wykes; J Kubus; J D Crissman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.

Authors:  D C Brown; K C Gatter
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

8.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Authors:  E Leonardi; S Girlando; G Serio; F A Mauri; G Perrone; S Scampini; P Dalla Palma; M Barbareschi
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

9.  USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

Authors:  Randy S Schrecengost; Jeffry L Dean; Jonathan F Goodwin; Matthew J Schiewer; Mark W Urban; Timothy J Stanek; Robyn T Sussman; Jessica L Hicks; Ruth C Birbe; Rossitza A Draganova-Tacheva; Tapio Visakorpi; Angelo M DeMarzo; Steven B McMahon; Karen E Knudsen
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

10.  Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.

Authors:  Kwang Hyun Paik; Yeon Hee Park; Baek-Yeol Ryoo; Sung Hyun Yang; Jae Cheol Lee; Cheol Hyun Kim; Seung Seog Ki; Jung Min Kim; Myung Joon Park; Heui June Ahn; Won Choi; Jin Haeng Chung
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.